Zobrazeno 1 - 10
of 138
pro vyhledávání: '"C. Oberhoff"'
Autor:
Martin Heubner, I. A. Schroer-Zuendorf, Rainer Kimmig, Oliver Hoffmann, C. Oberhoff, Sabine Kasimir-Bauer
Publikováno v:
Archives of Gynecology and Obstetrics. 292:1117-1125
About 30% of primary, non-metastatic breast cancer patients show a relapse of the disease years after first diagnosis, probably due to early tumor cell spread to the bone marrow (BM). For disseminated tumor cells (DTCs) in the BM, tumor cell dormancy
Publikováno v:
Geburtshilfe und Frauenheilkunde. 67:127-134
Publikováno v:
TumorDiagnostik & Therapie. 26:166-171
Autor:
C. Oberhoff, R. Schleucher, U. Vanhoefer, Manfred Kaufmann, S. Loibl, Anja Welt, D. Borquez, G. von Minckwitz, Siegfried Seeber, A. Harstrick
Publikováno v:
Annals of Oncology. 16:64-69
Purpose To define the maximum-tolerated dose (MTD) and to evaluate the dose-limiting toxicities (DLT) of the combination of capecitabine and vinorelbine in patients with metastatic breast cancer who relapse after adjuvant and/or first-line treatment.
Publikováno v:
Der Onkologe. 8:1309-1317
Innerhalb dieser Definition wird die Inzidenz des Schwangerschafts-assoziierten Mammakarzinoms mit 0,2–3,8% angegeben [1]. Die Diagnose eines Mammakarzinoms wird bei etwa 1:10.000 bis 1:3000 Schwangerschaften gestellt.Betrachtet man jedoch nur den
Autor:
H.J. Staab, W. Queisser, N. Harbeck, U. Meier, H. Stammberger, J. Hilfrich, G. Jessernigg, A. Krüger, P. Šlampa, J. Heymanns, R. Würstlein, J. Sehouli, C. Kolotas, A. Gugl, G.H.J. Mickisch, C. van Soest, A. Beham, P. Čoupek, G. Schackert, G. Fleckenstein, F. Wenz, W. Marbé, S. Sinz, R. Kuse, H. Köppler, S. Kopp, M. Scheer, R.E. Kates, C. Lohfert, N. Zamboglou, J.P. Bergerat, T.G. Wendt, J. Petera, S.B. Sobottka, M. Schmitt, A. Steinmetz, S. Kunert, M.E. Heim, H. Colberg, R. Weide, I. Özkan, S. Samel, H. Deertz, F. Jänicke, W. Wuttke, O. Kodalle, S. Filip, A.E. Schindler, S. Post, C. Oberhoff, C. Thomssen, B. Sattler, B. Hinney, R. Hofheinz, K.-H. Preisegger, R. Osmers, A.C. Kübler, J. Sturm, P. Kalmár, A. Hundt, P. Zatloukal, G. von Minckwitz, D.G. Kieback, Heidelberg P. Drings, M. Mesrogli, J.E. Zöller, M.R. Knoll, Wien H. Huber, R. Soumarová, G. Emons
Publikováno v:
Oncology Research and Treatment. 24:205-210
Publikováno v:
Gynecological Endocrinology. 15:341-348
Effects of high-dose megestrol acetate on blood coagulation and fibrinolysis were investigated in patients with gynecological (n = 13) and breast (n = 10) cancer. Patients received either 160 mg or 320 mg/day megestrol acetate orally. Blood sampling
Topotecan Chemotherapy in Patients with Breast Cancer and Brain Metastases: Results of a Pilot Study
Autor:
G. von Minckwitz, D. G. Kieback, H.J. Staab, Rachel Würstlein, Jörn Hilfrich, H. Deertz, M. Mesrogli, A. E Schindler, C. Oberhoff, C. van Soest, Jalid Sehouli
Publikováno v:
Oncology Research and Treatment. 24:256-260
Symptomatic brain metastases occur in approximately 10-15% of patients suffering from breast cancer and are linked to a clear deterioration of the patient's condition. Although radiotherapy is recommended as a primary therapy, the optimal management
Autor:
Ronald E. Kates, J. Dünnebacke, O Gluz, U. Nitz, V Runde, Toralf Reimer, John Hackmann, N. Belzl, C. Oberhoff, Doris Augustin, Claudia Schumacher, I. Zuna, Nadia Harbeck, Christoph Uleer, M. Warm
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 25(1)
Background: WSG-ARA plus trial evaluated the effect of adjuvant darbepoetin alfa (DA) on outcome in node positive primary breast cancer (BC). Patients and methods: One thousand two hundred thirty-four patients were randomized to chemotherapy either w
Autor:
R. Voigtmann, E. Merkle, U. Rebmann, A. E. Schindler, W. Gallasch, C. Oberhoff, O. Quarder, M. R. Nowrousian, M. Karthaus, C. Kasper, B. Krumeich, K. U. Petry
Publikováno v:
TumorDiagnostik & Therapie. 21:15-25